23340-69-4

Basic information

• Product Name: 5-CYANO-DIMETHYLISOPHTHALATE
• Synonyms: 5-CYANO-DIMETHYLISOPHTHALATE;DiMethyl 5-Cyanoisophthalate;Dimethyl 5-cyanobenzene-1,3-dicarboxylate
• CAS NO: 23340-69-4
• Molecular Formula: C₁₁H₉NO₄
• Molecular Weight: 219.19
• Mol File: 23340-69-4.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 339.2±32.0 °C(Predicted)
• Appearance: /
• Density: 1.27±0.1 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 5-CYANO-DIMETHYLISOPHTHALATE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-CYANO-DIMETHYLISOPHTHALATE(23340-69-4)
• EPA Substance Registry System: 5-CYANO-DIMETHYLISOPHTHALATE(23340-69-4)

Safety Data

• Hazardous Substances Data: 23340-69-4(Hazardous Substances Data)

Usage

General Description

5-Cyano-dimethylisophthalate is a chemical compound with the molecular formula C11H9NO4. It is a derivative of isophthalic acid, containing a cyano group and two methyl groups. 5-CYANO-DIMETHYLISOPHTHALATE is commonly used as a building block in organic synthesis and for the production of pharmaceuticals and other fine chemicals. It is a white to off-white crystalline powder with a high melting point, making it suitable for various industrial applications. 5-Cyano-dimethylisophthalate is also known for its potential use as a corrosion inhibitor in metalworking fluids and as a stabilizer in PVC and other polymers.

Upstream product

• 922-67-8 propynoic acid methyl ester 
• 105-34-0 methyl 2-cyanoacetate 
• 557-21-1 dicyanozinc 
• 168619-21-4 3,5-bis(methoxycarbonyl)phenyl trifluoromethanesulfonate 

Downstream Products

• 126739-90-0 5-cyano-isophthalic acid monomethyl ester 
• 243965-29-9 dimethyl 5-(3,4-dicyanophenoxy)-isophthalate 
• 1427577-61-4 3-[3,5-Bis(methoxycarbonyl)phenoxy] phthalonitrile 

Relevant articles and documents

AMIDE DERIVATIVES AS INHIBITORS OF ASPARTYL PROTEASES

The invention provides compounds of the formula (I). N-oxides, addition salts, quaternary amines, metal complexes, stereochemically isomeric forms and metabolites thereof, wherein W is H, C1-C6alkyl, C3-C6cycloalkyl, aryl or heterocyclyl; Q is aryl or heterocyclyl; A is a five or six membered saturated, partially unsaturated or aromatic ring; D is formula (II) or formula (III); and the other variables are as defined in the specification. The compounds of the invention are inhibitors of aspartyl proteases such as renin and BACE and are among other things useful for the treatment and/or prophylaxis of conditions associated with activities of the RAS, such as hypertension, heart failure and renal insufficiency and for the treatment and or prophylaxis of conditions associated with BACE activity such as of Alzheimer's disease.